Clinical Trials Sponsored by Rohto Pharmaceutical Co., Ltd.

Total 3869 results

Biotech Pharmaceutical Co., Ltd.

Not yet recruiting

Safety and Preliminary Clinical Activity of Itolizumab in Dermatomyositis

Dermatomyositis, Adult Type
Daewoong Pharmaceutical Co. LTD.

Not yet recruiting

Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 With DWC202307 in Healthy Adult Volunteers

Healthy Volunteers
Daewoong Pharmaceutical Co. LTD.

Recruiting

To Evaluate the Efficacy and Safety of Envlo Tablet or Envlomet SR Tablet in Patients With Type II Diabetes Mellitus

Diabetes Mellitus, Type 2

Korea, Republic of
Ono Pharmaceutical Co. Ltd

Recruiting

A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy

Multiple System Atrophy (MSA)

United States
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Phase I Study of QLP2117 in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

China
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Phase I Study of QLS12004 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Biotech Pharmaceutical Co., Ltd.

Recruiting

Safety and Clinical Activity of Itolizumab in aGVHD

Acute Graft Versus Host Disease

China
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of Olanzapine in Patients With Acute Agitation

Acute Agitation
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in Patients With Breast Cancer

To Evaluate the Effectiveness of GM1 in the Prevention of Albumin-paclitaxel Therapy Induced Peripheral Neuropathy in Breast Cancer Patients
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19

COVID-19

China
Daewoong Pharmaceutical Co. LTD.

Recruiting

To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic Function

Diabetes Mellitus, Type 2

Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.

Recruiting

Samtasu Post-marketing General Drug Use-results Survey in Patients With Volume Overload in Heart Failure.

Heart Failure

Japan
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Phase 2 Study to Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to Moderate COVID-19

COVID-19

China
Daewoong Pharmaceutical Co. LTD.

Recruiting

Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia

Hypertension | Dyslipidemias

Korea, Republic of
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma

Advanced Liver Cancer

China
Boryung Pharmaceutical Co., Ltd

Recruiting

An OS to Evaluate the Safety & Efficacy of Fixed Dose Combination Therapy With Atorvastatin and Ezetimibe (LITE)

Primary Hypercholesterolemia

Korea, Republic of
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Phase II Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Cervical Cancer

Cervical Cancer

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

Evaluating the Efficacy and Safety of QL0911 in the Prevention of Chemotherapy- Induced Thrombocytopenia

Chemotherapy-induced Thrombocytopenia

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

To Evaluate the Efficacy of QLH11811 in Advanced NSCLC Patients With EGFR Mutation

Non-small Cell Lung Cancer

China
Ono Pharmaceutical Co. Ltd

Recruiting

A Study to Investigate the Safety, Tolerability, PK, PD, and Efficacy of ONO-7018 in Patients With R/R NHL or CLL

Lymphoma, Non-Hodgkin | Leukemia, Lymphocytic, Chronic, B-Cell

United States
Qilu Pharmaceutical Co., Ltd.

Recruiting

Safety, Tolerability and Pharmacokinetics Study of QLS31904 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Study of QLS1128 and in Combination With Ritonavir in Healthy Participants

COVID-19

China
Daewoong Pharmaceutical Co. LTD.

Recruiting

Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab

Hypertension | Hyperlipidemias

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Recruiting

Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF

Idiopathic Pulmonary Fibrosis

United States, Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.

Recruiting

A Long-term Administration Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia

Schizophrenia

Japan
Jeil Pharmaceutical Co., Ltd.

Recruiting

To Evaluate the Efficacy and Safety of JT-003 add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin

Type 2 Diabetes Mellitus

Korea, Republic of
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Study of QLS31905 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Taejoon Pharmaceutical Co., Ltd.

Recruiting

A Phase 1 Clinical Trial to Explore Systemic Exposure of CTO0101 Eye Drops, Safety and Local Tolerability in Healthy Adults

Healthy

Korea, Republic of
Taiho Pharmaceutical Co., Ltd.

Recruiting

A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101)

Gastrointestinal Stromal Tumors

Taiwan, Japan, China, Australia, Singapore
Dongkook Pharmaceutical Co., Ltd.

Recruiting

Efficacy and Safety of DKF-306 in Patients With Periodontal Diseases

Periodontal Diseases

Korea, Republic of
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

Meropenem-FL058 Phase 2 Study in the Treatment of Complicated Urinary Tract Infections

Acute Pyelonephritis | Complicated Urinary Tract Infection
IlDong Pharmaceutical Co Ltd

Recruiting

IDG-16177 for the Evaluation of Its Safety and Pharmacokinetics

Type 2 Diabetes

Germany
Otsuka Pharmaceutical Co., Ltd.

Recruiting

Samsca Post-marketing General Drug Use-results Survey in Patients With Hyponatremia in SIADH

Antidiuretic Hormone, Inappropriate Secretion

Japan
Daewoong Pharmaceutical Co. LTD.

Not yet recruiting

Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507

Dyslipidemias
Biotech Pharmaceutical Co., Ltd.

Recruiting

Nimotuzumab in Combined With Chemoradiotherapy to Treat the Newly Diagnosed Diffuse Intrinsic Pontine Glioma in Children

Diffuse Intrinsic Pontine Glioma

China
Boryung Pharmaceutical Co., Ltd

Recruiting

Oxaliplatin Adjuvant Chemotherapy After Curative Resection of Primary Colon Cancer (OCEAN)

Stage II Colon Cancer | Stage III Colon Cancer

Korea, Republic of
Qilu Pharmaceutical Co., Ltd.

Recruiting

QL1604 Monotherapy for dMMR or MSI-H Advanced Solid Tumors

Advanced Malignant Tumor

China
IlDong Pharmaceutical Co Ltd

Recruiting

A Post-marketing Surveillance to Assess Safety and Efficacy of Twotopsplus.

Hypertension

Korea, Republic of
IlDong Pharmaceutical Co Ltd

Not yet recruiting

A Post-marketing Surveillance to Assess Safety and Efficacy of Telostop Plus Tab.

Hypertension, Dyslipidemia
Daewoong Pharmaceutical Co. LTD.

Completed

To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy

Gastric Cancer

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

Freestyle Libre-based Education on MDI in T2DM (FreEdoM-2)

Type 2 Diabetes Mellitus

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3005" and Co-administration of "BR3005-1" and "BR3005-2" Under Fasting Conditions in Healthy Adult Volunteers

Type 2 Diabetes Mellitus

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3005" and Co-administration of "BR3005-1" and "BR3005-2" Under Fed Conditions in Healthy Adult Volunteers

Type2 Diabetes Mellitus

Korea, Republic of
Ono Pharmaceutical Co. Ltd

Suspended

Safety, Tolerability, PK, PD and Preliminary Efficacy of ONO-4685

Plaque Psoriasis

United Kingdom, Moldova, Republic of, Romania
Ono Pharmaceutical Co. Ltd

Completed

ONO-4538 Phase I Study in Patients With Solid Tumor

Advanced Solid Tumors | Recurrent Solid Tumors

Korea, Republic of
Ono Pharmaceutical Co. Ltd

Completed

Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD of ONO-4685 in Japanese and Caucasian Healthy Adult Male Subjects

Healthy Volunteers

Japan
Ono Pharmaceutical Co. Ltd

Active, not recruiting

Study of ONO-4578 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors

Japan
Daewoong Pharmaceutical Co. LTD.

Completed

DWP450 for Treating Moderate to Severe Glabellar Lines

Moderate to Severe Glabellar Lines

China
Ono Pharmaceutical Co. Ltd

Completed

A Phase 1 Study of ONO-2020 in Healthy Participants

Healthy Volunteers

United States
Ono Pharmaceutical Co. Ltd

Completed

Multiple-dose Study of FOY-305 in Japanese Healthy Adult Male Subjects

Healthy Volunteers

Japan

3

Subscribe